Thus, our team has begun developing and conducting treatment studies to test rehabilitative paradigms that are based on this fundamental neuroscience knowledge. The Intensive Dysphagia Rehabilitation ...

It can make it difficult to eat certain foods, difficult to get adequate nutrients, and generally just difficult to function ...

Her review found all three experimental treatments showed therapeutic potential for patients with dysphagia caused by stroke and other neurological causes and were tolerable without serious adverse ...

Conditions like thrush, strep throat (bacterial tonsils), or other infections affecting the throat can cause pain and inflammation that lead to temporary dysphagia. Treatment for head and neck cancers ...

This article delves into the symptoms, causes, risk factors, and potential treatments of dysphagia. Symptoms to Watch For: 1. Cough: As soon as food or liquid is placed in the mouth, you may notice a ...

Dysphagia can be categorized as oropharyngeal ... and coexisting conditions guide the overall approach to treatment. Efficacy is based on clinical response instead of antibody titers.

Throat cancer recovery dysphagia "Dysphagia" means difficulty swallowing foods or drinks. Some of the treatments for throat cancer can cause dysphagia. Surgery to the pharynx or larynx can make ...

Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis: Victoria, British Columbia Thursday, November 14, 2024, ...

Clinical research goals are the development of novel and robust evaluation and treatment techniques for dystussia and dysphagia. Our current projects focus on multiple behaviors contributing to airway ...

At this point, a total of 286 patients had received treatment with 360 mg of cendakimab once weekly, and 143 had received placebo. The change in dysphagia days was −6.1 in patients on cendakimab ...

Straumann Dysphagia Index, a patient-reported outcome measure designed ... Using data from four biopsy sites, which is consistent with the FDA Guidance for Developing Drugs for the Treatment of EoE, ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...